454 related articles for article (PubMed ID: 29641565)
1. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
[TBL] [Abstract][Full Text] [Related]
2. Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.
Hinamoto N; Maeshima Y; Yamasaki H; Nasu T; Saito D; Watatani H; Ujike H; Tanabe K; Masuda K; Arata Y; Sugiyama H; Sato Y; Makino H
PLoS One; 2014; 9(9):e107934. PubMed ID: 25255225
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
[TBL] [Abstract][Full Text] [Related]
4. Preventive effects of vasohibin-2-targeting peptide vaccine for diabetic nephropathy.
Nakashima Y; Tanabe K; Mifune T; Nakadoi T; Hayashi H; Nakagami H; Sato Y; Wada J
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F1054-F1065. PubMed ID: 38695075
[TBL] [Abstract][Full Text] [Related]
5. Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.
Nasu T; Maeshima Y; Kinomura M; Hirokoshi-Kawahara K; Tanabe K; Sugiyama H; Sonoda H; Sato Y; Makino H
Diabetes; 2009 Oct; 58(10):2365-75. PubMed ID: 19587360
[TBL] [Abstract][Full Text] [Related]
6. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
[TBL] [Abstract][Full Text] [Related]
7. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
[TBL] [Abstract][Full Text] [Related]
8. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
9. Glomerular injury is exacerbated in diabetic integrin alpha1-null mice.
Zent R; Yan X; Su Y; Hudson BG; Borza DB; Moeckel GW; Qi Z; Sado Y; Breyer MD; Voziyan P; Pozzi A
Kidney Int; 2006 Aug; 70(3):460-70. PubMed ID: 16775606
[TBL] [Abstract][Full Text] [Related]
10. High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells.
Kitsunai H; Makino Y; Sakagami H; Mizumoto K; Yanagimachi T; Atageldiyeva K; Takeda Y; Fujita Y; Abiko A; Takiyama Y; Haneda M
Physiol Rep; 2016 Mar; 4(6):. PubMed ID: 27033449
[TBL] [Abstract][Full Text] [Related]
11. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.
Klemis V; Ghura H; Federico G; Würfel C; Bentmann A; Gretz N; Miyazaki T; Gröne HJ; Nakchbandi IA
Kidney Int; 2017 Jun; 91(6):1374-1385. PubMed ID: 28159318
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.
Saito D; Maeshima Y; Nasu T; Yamasaki H; Tanabe K; Sugiyama H; Sonoda H; Sato Y; Makino H
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F873-86. PubMed ID: 21228103
[TBL] [Abstract][Full Text] [Related]
13. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
[TBL] [Abstract][Full Text] [Related]
14. Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model.
Boonloh K; Lee ES; Kim HM; Kwon MH; Kim YM; Pannangpetch P; Kongyingyoes B; Kukongviriyapan U; Thawornchinsombut S; Lee EY; Kukongviriyapan V; Chung CH
Eur J Nutr; 2018 Mar; 57(2):761-772. PubMed ID: 28004272
[TBL] [Abstract][Full Text] [Related]
15. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
[TBL] [Abstract][Full Text] [Related]
16. 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.
Ichinose K; Maeshima Y; Yamamoto Y; Kinomura M; Hirokoshi K; Kitayama H; Takazawa Y; Sugiyama H; Yamasaki Y; Agata N; Makino H
Diabetes; 2006 May; 55(5):1232-42. PubMed ID: 16644677
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice.
Craven PA; Melhem MF; Phillips SL; DeRubertis FR
Diabetes; 2001 Sep; 50(9):2114-25. PubMed ID: 11522679
[TBL] [Abstract][Full Text] [Related]
18. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
20. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
